Todd A. Triplett
Affiliations: | University of Texas at Austin, Austin, Texas, U.S.A. |
Google:
"Todd Triplett"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Holay N, Somma A, Duchow M, et al. (2023) Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy. Frontiers in Immunology. 14: 1260545 |
| Lyu A, Triplett TA, Nam SH, et al. (2020) Tumor-associated myeloid cells provide critical support for T-ALL. Blood |
| Bloom MJ, Jarrett AM, Triplett TA, et al. (2020) Anti-HER2 induced myeloid cell alterations correspond with increasing vascular maturation in a murine model of HER2+ breast cancer. Bmc Cancer. 20: 359 |
| Warden AS, Triplett TA, Lyu A, et al. (2020) Microglia depletion and alcohol: Transcriptome and behavioral profiles. Addiction Biology. e12889 |
| Bloom M, Jarrett A, Triplett T, et al. (2019) Abstract P4-06-17: Investigating trastuzumab-induced myeloid cell alterations for improving combination therapy in HER2+ breast cancer Cancer Research. 79 |
| Bloom MJ, Jarrett AM, Triplett TA, et al. (2019) Abstract 187: Trastuzumab induced myeloid cell alterations identifies mechanistic properties of vascular normalization Cancer Research |
| Miljanic M, Holay N, Capasso A, et al. (2019) Abstract 4753: Attenuating colorectal cancer cell growth and enhancing immunogenicity through rational combination of MEK and HDAC inhibition Cancer Research. 79: 4753-4753 |
| Triplett TA, Garrison KC, Marshall N, et al. (2018) Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme. Nature Biotechnology |
| Triplett TA, Triplett K, Stone E, et al. (2017) Abstract 5571: Immune-checkpoint inhibition via enzyme-mediated degradation of kynurenine Cancer Research. 77: 5571-5571 |
| Zhang M, Stone E, Triplett TA, et al. (2017) Abstract 5570: A novel approach to targeting the IDO/TDO pathway through degradation of the immunosuppressive metabolite kynurenine Cancer Research. 77: 5570-5570 |